Molecular signature incorporating the immune microenvironment enhances thyroid cancer outcome prediction

• Main Authors: George J. Xu (Author), Matthew A. Loberg (Author), Jean-Nicolas Gallant (Author), Quanhu Sheng (Author), Sheau-Chiann Chen (Author), Brian D. Lehmann (Author), Sophia M. Shaddy (Author), Megan L. Tigue (Author), Courtney J. Phifer (Author), Li Wang (Author), Mario W. Saab-Chalhoub (Author), Lauren M. Dehan (Author), Qiang Wei (Author), Rui Chen (Author), Bingshan Li (Author), Christine Y. Kim (Author), Donna C. Ferguson (Author), James L. Netterville (Author), Sarah L. Rohde (Author), Carmen C. Solórzano (Author), Lindsay A. Bischoff (Author), Naira Baregamian (Author), Aaron C. Shaver (Author), Mitra Mehrad (Author), Kim A. Ely (Author), Daniel W. Byrne (Author), Thomas P. Stricker (Author), Barbara A. Murphy (Author), Jennifer H. Choe (Author), Luciane T. Kagohara (Author), Elizabeth M. Jaffee (Author), Eric C. Huang (Author), Fei Ye (Author), Ethan Lee (Author), Vivian L. Weiss (Author)
• Format: Book
• Published: Elsevier, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Genomic and transcriptomic analysis has furthered our understanding of many tumors. Yet, thyroid cancer management is largely guided by staging and histology, with few molecular prognostic and treatment biomarkers. Here, we utilize a large cohort of 251 patients with 312 samples from two te...